The New Dental AI Divide

Dentistry has a substantial digital infrastructure. Intraoral scans, CBCT, CAD/CAM, digital smile design, cloud case transfer, guided surgery, remote monitoring, milling, and 3D printing are already used across many workflows. Recent reviews describe AI as being introduced into these existing digital systems rather than replacing them. [19]

That makes supervision and workflow control central implementation issues.

AI is entering dentistry as a proposal engine

Commercial dental AI products are often presented as assistive tools within existing workflows.

In labs, AI is being embedded in design software as a proposal generator. 3Shape’s Automate describes itself as an AI-powered design service for common indications, states that it has processed millions of cases, and says users review, approve, and edit designs before production. exocad’s AI Design similarly presents AI-generated crown design suggestions that work within existing DentalCAD workflows and use existing parameters and preferences. [10]

These products are marketed as tools for generating draft designs, not as autonomous replacements for laboratory review.

A similar pattern appears in clinical use. The FDA’s AI/ML software-as-a-medical-device framework emphasizes lifecycle management, transparency, and oversight for AI-enabled devices. The FDA De Novo authorization for DentalMonitoring describes the device in terms of orthodontic treatment monitoring with provider involvement rather than autonomous care. [1]

Current evidence therefore supports describing many near-term dental AI applications as systems that draft, flag, propose, or monitor while human users retain responsibility for review and use.

The bottleneck is no longer the algorithm alone

Model performance is only one part of implementation in dentistry.

The utility of AI in dental workflows depends on factors such as input quality, workflow integration, validation, review procedures, and the handling of exceptions. In imaging, for example, the ADA technical report on evaluating dental image analysis systems focuses on how these systems should be assessed and compared rather than assuming that output alone is sufficient evidence of usefulness. [8]

This emphasis appears in current standards work. The ADA has published a 2022 white paper on AI uses in dentistry and a 2025 technical report on evaluating dental image analysis systems. ADA reporting on the 2025 document highlights the use of independent datasets held by third parties rather than manufacturers for comparison of systems. [6]

These documents show that evaluation methodology is becoming a formal part of AI adoption in dentistry.

Dentistry is becoming a quality-assurance profession in new ways

As AI tools are introduced into digital dental workflows, human work remains concentrated in review, correction, exception handling, esthetic judgment, patient communication, and accountability.

This is visible in commercial lab software. 3Shape describes a review-and-approve workflow in which the lab user retains final control. exocad states that AI suggestions use existing dentist-specific defaults and production parameters. [10]

Broader AI implementation literature also emphasizes workflow integration and oversight. McKinsey has described value creation from generative AI in terms of workflow redesign, and BCG has argued that human oversight requires defined processes rather than informal review alone. [28]

In dentistry, this supports the importance of defined review procedures, approval criteria, and escalation pathways when AI systems are used in production or clinical settings. The same considerations apply to imaging and monitoring software, where review, documentation, and performance monitoring remain operational requirements. [1]

The biggest risk is silent failure

A major concern in AI-enabled dental workflows is the possibility of plausible but incorrect output passing into later stages of care or manufacture without detection.

Examples described in the literature and standards context include errors in design, segmentation, monitoring, and image analysis that may not be obvious at first review. This concern is consistent with recurring themes in regulatory and standards documents: transparency, dataset quality, bias, validation, post-market monitoring, and lifecycle management. FDA materials on AI-enabled device software functions address predetermined change control plans for AI-enabled devices, reflecting the need for continued oversight after initial authorization. NIST’s generative AI profile presents risk management as a lifecycle activity. WHO’s 2024 guidance on large multimodal models in health care identifies risks including error, bias, privacy concerns, and overreliance. [1]

Taken together, these sources support the need for quality-assurance controls around AI-enabled dental workflows.

The market is moving faster than universal validation

Commercial adoption and standards activity are advancing alongside a still-developing evidence base.

Major dental software vendors are embedding AI into design workflows. FDA-authorized dental-category AI-enabled devices now appear in federal listings. The ADA has published AI-specific standards documents. NIDCR and related institutions are supporting AI-related oral-health research, including work related to materials design and data infrastructure. [10]

At the same time, review articles describe rapid innovation across diagnosis, treatment planning, prosthodontics, and CAD/CAM while also noting uneven validation and limited evidence across full end-to-end workflows. [18]

The evidence therefore supports a distinction between commercial availability and comprehensive validation across all settings and workflows.

The competitive edge may look boring from the outside

Available evidence from enterprise AI implementation outside dentistry indicates that organizations often struggle to scale value from AI and that workflow design, governance, and change management affect results. BCG reported in October 2024 that 74% of companies were struggling to achieve and scale value from AI, and McKinsey has similarly emphasized the role of organizational redesign in realizing value. [31]

Applied to dentistry, that evidence supports the relevance of validation, auditing, governance, and workflow integration when adopting AI tools. The profession does not require all dental professionals to become software developers in order to use AI systems, but safe and effective use does require structured review and oversight.

What this means for labs, clinics, and the companies serving them

For dental labs, current commercial tools and the surrounding literature support treating AI as a production technology used within defined indications and review processes. Metrics such as remake rates, turnaround times, and exception volume are relevant for local evaluation after deployment. Vendor-reported acceptance rates may provide product information, but they do not replace local validation. [10]

For clinicians, implementation requires understanding whether a tool functions as decision support or as a regulated medical device function, the degree of review required, and how responsibility and documentation are handled in practice. [1]

For DSOs and group practices, procurement, validation, user training, escalation rules, and outcome monitoring are governance issues that can be standardized across sites. [15]

For manufacturers and software companies, current evidence supports the importance of features that make outputs reviewable and auditable within workflows, including editability, traceability, confidence signaling, interoperability, and exception handling. [12]

For educators, current ADA materials support teaching AI-related judgment skills, including task framing, output review, recognition of failure modes, and understanding of validation limits in digital dental workflows. [6]

Dentistry’s next skill may be orchestration

The available evidence supports several points simultaneously.

AI can be useful in dental workflows while still requiring human review. It can improve speed or consistency in some tasks while also introducing new failure modes. It can increase productivity in parts of a workflow while increasing the importance of oversight, validation, and quality control.

In a field where digital workflows already connect scan, image, design, manufacture, and delivery, the ability to supervise and coordinate AI-enabled systems is becoming an important operational skill. [21]

Practical Implications

• Dental labs should treat AI as a scoped production tool, not a blanket replacement strategy. Start with repeatable indications, define approval criteria, and track remake rates, turnaround time, and exception volume after deployment. [10]

• Clinicians need supervisory literacy more than technical literacy. The key skill is judging when an AI output is trustworthy, when it is incomplete, and how to document review and responsibility. [1]

• DSOs should govern AI centrally. Procurement, validation, user training, escalation rules, and ongoing outcome monitoring should be standardized across sites rather than left to local improvisation. [31]

• Manufacturers should compete on trust infrastructure. Editable outputs, transparent workflow fit, auditability, and interoperability may matter as much as headline model performance. [12]

• Educators should teach AI judgment. Students and technicians need training in prompt framing, output review, failure detection, and the limits of validation—not just exposure to new tools. [6]

• Independent validation is becoming strategically important. The push for third-party datasets and standardized evaluation suggests that buyer skepticism will increasingly focus on evidence quality, not just vendor claims. [8]

• The biggest operational risk is silent error propagation. The faster AI makes a workflow, the more valuable QA checkpoints become. [15]